{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T11:56:23Z","timestamp":1793793383487,"version":"4.6.1"},"reference-count":9,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofcardiologycases.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology Cases"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jccase.2025.04.007","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T15:57:48Z","timestamp":1746201468000},"page":"47-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Severe tirofiban-induced thrombocytopenia following percutaneous coronary intervention"],"prefix":"10.1016","volume":"32","author":[{"given":"John M.","family":"Sousou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kabeer","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melville C.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy M.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadi","family":"Kandah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Franchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jccase.2025.04.007_bb0005","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1517\/13543784.6.9.1257","article-title":"Tirofiban: an investigational platelet glycoprotein IIb\/IIIa receptor antagonist","volume":"6","author":"Kumar","year":"1997","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.jccase.2025.04.007_bb0010","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0735-1097(02)02666-9","article-title":"Intravenous glycoprotein IIb\/IIIa receptor antagonists reduce mortality after percutaneous coronary interventions","volume":"41","author":"Karvouni","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jccase.2025.04.007_bb0015","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.3389\/fphar.2018.01456","article-title":"A simple clinical pre-procedure risk model for predicting thrombocytopenia associated with periprocedural use of tirofiban in patients undergoing percutaneous coronary intervention","volume":"9","author":"Yi","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jccase.2025.04.007_bb0020","doi-asserted-by":"crossref","first-page":"2233425","DOI":"10.1080\/07853890.2023.2233425","article-title":"Tirofiban-induced thrombocytopenia","volume":"55","author":"Wang","year":"2023","journal-title":"Ann Med"},{"key":"10.1016\/j.jccase.2025.04.007_bb0025","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1046\/j.1538-7836.2003.00270.x","article-title":"Heparin-induced thrombocytopenia","volume":"1","author":"Chong","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jccase.2025.04.007_bb0030","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1016\/j.jacc.2014.09.017","article-title":"2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines","volume":"64","author":"Amsterdam","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jccase.2025.04.007_bb0035","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1080\/09537100500140141","article-title":"Two distinct subgroups of tirofiban-induced thrombocytopenia exist due to drug dependent antibodies that cause platelet activation and increased ischaemic events","volume":"16","author":"Dunkley","year":"2005","journal-title":"Platelets"},{"key":"10.1016\/j.jccase.2025.04.007_bb0040","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1182\/blood.V100.6.2071","article-title":"Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb\/IIIa","volume":"100","author":"Bougie","year":"2002","journal-title":"Blood"},{"issue":"2 Suppl","key":"10.1016\/j.jccase.2025.04.007_bb0045","doi-asserted-by":"crossref","first-page":"e495S","DOI":"10.1378\/chest.11-2303","article-title":"Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Linkins","year":"2012","journal-title":"Chest"}],"container-title":["Journal of Cardiology Cases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878540925000374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878540925000374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T02:46:06Z","timestamp":1782960366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878540925000374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1878540925000374"],"URL":"https:\/\/doi.org\/10.1016\/j.jccase.2025.04.007","relation":{},"ISSN":["1878-5409"],"issn-type":[{"value":"1878-5409","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severe tirofiban-induced thrombocytopenia following percutaneous coronary intervention","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology Cases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jccase.2025.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Japanese College of Cardiology. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}